Announced Thu, 9 Jul · 14:53 IST
Eris Lifesciences files quarterly RTA certificate under SEBI Reg 74(5)
Compliance View source PDF
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.6%1-day move
₹1418.10
prior close
₹1432.20
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.4—-0.1-0.3+0.6+2.6+1.7+3.0+4.3+3.2————
Up moveDown movePending
AI summary
Eris Lifesciences has submitted a confirmation certificate under SEBI Regulation 74(5) of the Depositories and Participants Regulations, 2018, for the quarter ended 30th June 2026. The certificate, issued by its Registrar and Share Transfer Agent MUFG Intime India (formerly Link Intime), confirms that share certificates received for dematerialisation were processed and the underlying securities are listed on the stock exchanges. This is a routine quarterly compliance filing with no new business action.
Likely market impact
Routine procedural compliance filing. No impact on shareholders, operations, or stock price.